Further efforts in determining the crucial role of HLA, KIR and GM genes in HCMV control will greatly enhance our understanding of the immunogenetic aspects of HCMV infections, and to potentially apply this knowledge clinically, i.e., in the development of new vaccines and in the identification of new therapeutic targets. The gene discussed is PPP1R3A; the disease is cytomegalovirus infection.